| CTRI Number |
CTRI/2022/06/043615 [Registered on: 30/06/2022] Trial Registered Prospectively |
| Last Modified On: |
29/06/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Behavioral Other (Specify) [Therapeutic Patient Education] |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Randomised controlled trial for role of patient education in chronic migraine management |
|
Scientific Title of Study
|
Efficacy of combination of therapeutic patient education with standard of care versus standard of care alone for the management of chronic migraine: A randomized controlled trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Debashish Chowdhury |
| Designation |
Director Professor and Head, Department of Neurology |
| Affiliation |
GB Pant Institute Postgraduate Medical Education and Research |
| Address |
Neurology Office
5th floor, Academic Block
G.I.P.M.E.R.
1, Jawaharlal Nehru Marg, 64 Khamba, Raj Ghat, New Delhi
Central DELHI 110002 India |
| Phone |
|
| Fax |
|
| Email |
debashishchowdhury@hotmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Mridula Garg |
| Designation |
M.B.B.S. Student |
| Affiliation |
GB Pant Institute Postgraduate Medical Education and Research |
| Address |
Neurology Office
5th floor, Academic Block
G.I.P.M.E.R.
1, Jawaharlal Nehru Marg, 64 Khamba, Raj Ghat, New Delhi
Central DELHI 110002 India |
| Phone |
9811230029 |
| Fax |
|
| Email |
gargmridula7@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Mridula Garg |
| Designation |
M.B.B.S. Student |
| Affiliation |
GB Pant Institute Postgraduate Medical Education and Research |
| Address |
Neurology Office
5th floor, Academic Block
G.I.P.M.E.R.
1, Jawaharlal Nehru Marg, 64 Khamba, Raj Ghat, New Delhi
Central DELHI 110002 India |
| Phone |
9811230029 |
| Fax |
|
| Email |
gargmridula7@gmail.com |
|
|
Source of Monetary or Material Support
|
| Institute of Study - GB Pant Insititute of Postgraduate Medical Education and Research, New Delhi |
|
|
Primary Sponsor
|
| Name |
Not applicable |
| Address |
Not applicable |
| Type of Sponsor |
Other [Nil] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Mridula Garg |
GB Pant Insititute of Postgraduate Medical Education and Research |
GB Pant Institute of Postgraduate Medical Education and Research
1, Jawaharlal Nehru Marg, 64 Khamba, Raj Ghat, New Delhi, Delhi 110002 Central DELHI |
9811230029
gargmridula7@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Maulana Azad Medical College and associated hospitals |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: G437||Chronic migraine without aura, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Standard of care alone |
The control group would be provided with standard of care for chronic migraine as per latest guidelines only. |
| Intervention |
Therapeutic patient education with standard of care |
Imparted as lectre- type sessions to patients in intervention group at regular intervals. This will be accompanied by standard of care treatment for chronic migraine as per latest guidelines. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
Any patient fulfilling diagnostic criteria for chronic migraine with or without aura as laid by ICHD-3 (International Classification of Headache Disorders) |
|
| ExclusionCriteria |
| Details |
All patients with a clinical phenotype of chronic migraine but on further investigation, found to have a secondary cause for their headache |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
|
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Change in Migraine Specific Quality of Life Score from baseline per 4 weeks for weeks 9-12 weeks |
12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Change in mean Headache Impact Test-6 from baseline per 4 weeks for weeks 9-12 weeks |
12 weeks |
| Change in mean Migraine Disability Assessment from baseline per 4 weeks for weeks 9-12 weeks |
12 weeks |
|
|
Target Sample Size
|
Total Sample Size="126" Sample Size from India="126"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/07/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="5" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study is a randomised control trial to objectively measure the efficacy of therapeutic patient education with standard of care compared with standard of care alone for the management of chronic migraine. Chronic migraine is a prevalent, debilitating condition that affects patients lifelong and hampers their everyday life and productivity. While drug treatment is available, it comes with its own caveat of Medicine Overuse Headache (MOH), and other side effects. There is burning need for behavioral interventions such as education to make lifestyle modifications that lead towards better patient outcome. This is key to health promotion. |